Researchers evaluate benmelstobart, with or without anlotinib, for use as consolidation therapy after chemoradiotherapy in ...

In a phase 2 trial, oral brepocitinib improves skin disease activity and quality of life in adults with cutaneous sarcoidosis ...

In patients with aortic stenosis accompanied by at least one risk factor, transcatheter valve replacement produces a large ...

Even in patients most likely to benefit, a 25-year follow-up in the landmark COURAGE trial has not shown percutaneous ...

A phase 2 trial compares dual-targeted CAR T-cell therapy with R-GemOx as second-line treatment for patients with relapsed or ...

Elevated pulmonary artery systolic pressure is linked to lower survival after a heart transplant, despite pulmonary vascular ...

Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead ...

An education intervention for advanced CKD patients on treatment options shows benefits in informed care-planning decisions, ...

Any uteroplacental disorder signals a higher risk for cardiovascular disease in women, both soon after delivery and later in ...

Pulsed field ablation for atrial fibrillation is linked to a lower rate of atrial arrhythmia recurrence within 24 months than ...

With the highest objective response rate in a phase 3 trial, Serono says its CSF-1R inhibitor is a potential 'best-in-class.' ...

Textile dye allergy remains a concern in Italy, with nearly 4% of patch‑tested patients reacting and roughly 60% of reactions ...